Although not required, Mylan uses state-of-the-art monitoring systems that can automatically evaluate and reject a product that does not meet specifications. This advanced technology is used to automatically remove a defective product from production or packaging lines.

Quality begins at step one. Mylan uses an established testing and verification process to ensure the suitability of active ingredients used in our medicines.

Mylan assures product potency, purity and drug release until expiry date by testing the stability of our products at specific intervals.

Customers count on you for advice. That's one of the reasons Mylan applies one global quality standard across our facilities and across our product line, regardless of market.

To ensure that you provide your patients with the highest quality medicines, Mylan uses advanced testing and monitoring systems to assure product adheres to testing acceptance criteria that are in alignment with requirements established by standard-setting organizations around the world.

Strengths: 10 mg,20 mg
DIN: 02309467, 02309475
Launch Date: September 10, 2014

Strengths: 250 mg/100 mg
DIN: 02402165
Launch Date: March 7, 2014

Strengths: 0.5 mg, 1.0 mg, 2.0 mg, 3.0 mg, 4.0 mg
DIN: 02413485, 02413493, 02413507, 02413515, 02413523
Launch Date: April 4, 2014

Strengths: 5 mg, 10 mg
DIN: 02359472, 02359480
Launch Date: December 27, 2013

Strengths: 0.2 mg/hr, 0.4 mg/hr, 0.6 mg/hr, 0.8 mg/hr
DIN: 02407442, 02407450, 02407469, 02407477
Launch Date: October 29, 2013

Strengths: 150 mg, 300 mg
DIN: 02382075, 02382083
Launch Date: October 21, 2013

Strengths: 150 mg
DIN: 02397773
Launch Date: October 17, 2013